Monitor for a prospectus supplement or takedown notice that would specify the size, price, and terms of any offering. The shelf enables the company to raise capital at its discretion, which may pressure the stock if a significant dilutive offering materializes.
IMA drugs
IMA drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 7 $5.69entry
- T+1 · 3mo ago +0.53%α +0.56% · $5.72
- T+5 · 3mo ago +2.64%α +2.24% · $5.84
- T+20 · 2mo ago −14.76%α −14.37% · $4.85
- T+60 · 15d ago −27.94%α −25.81% · $4.10
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ImageneBio's registration statement (File No. 333-290108) became effective on August 6, 2026, under the Securities Act of 1933. This enables the company to sell securities pursuant to the shelf registration, creating a potential dilution overhang for existing shareholders.
Key Facts
- Effectiveness date: 2026-08-06
- SEC File No.: 333-290108
- Act: Securities Act of 1933 (33 Act)
- Shelf registration became effective; no specific terms of offering disclosed
Financial Impact
No offering amount, price, or number of shares specified in the effectiveness notice; dilution potential exists but is unquantifiable from this filing alone
Risk Factors
- Potential dilution to existing shareholders upon any future shelf takedown
- No disclosure of intended use of proceeds or timing of offering
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002555 |
| Document: 9999999995-26-002555-index.html | 9999999995-26-002555 |
| Document: 9999999995-26-002555.txt | 9999999995-26-002555 |
Track record
10 reports on IMA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $3.50 Now $3.20 −8.57% settles Feb 12
- Nov 9, 20267d ago 8-K Neutral 4/10 Entry $3.81 Now $3.20 −16.01% settles Feb 8
- Aug 7, 202614w ago EFFECT Bearish 5/10 Viewing Entry $5.69 to $4.10 Now $3.20 +43.76% ▲ +27.94% +25.81% vs SPY
- Jun 26, 202620w ago 8-K Neutral 3/10 Entry $6.07 to $4.85 Now $3.20 −47.28% ▼ −20.10% −24.48% vs SPY
- Apr 30, 202628w ago DEFA14A Neutral 3/10 Entry $5.66 to $5.76 Now $3.20 −43.46% ▲ +1.77% −1.30% vs SPY
- Apr 13, 202631w ago 8-K Bearish 6/10 Entry $6.05 to $5.93 Now $3.20 +47.11% ▲ +2.07% +10.99% vs SPY
- Apr 13, 202631w ago Press Release Bearish 6/10 Entry $6.05 to $5.93 Now $3.20 +47.11% ▲ +2.07% +10.99% vs SPY
- Apr 6, 202632w ago EFFECT Neutral 3/10 Entry $4.55 to $5.77 Now $3.20 −29.67% ▲ +26.81% +13.34% vs SPY
- Mar 17, 202634w ago Press Release Neutral 3/10 Entry $5.83 to $5.71 Now $3.20 −45.06% ▼ −1.97% −13.50% vs SPY
- Mar 10, 202635w ago Press Release Neutral 4/10 Entry $6.07 to $5.45 Now $3.20 −47.28% ▼ −10.21% −21.90% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers